SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010064
Filing Date
2017-05-10
Accepted
2017-05-10 07:34:10
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itek-10q_20170331.htm 10-Q 1723069
2 EX-31.1 itek-ex311_9.htm EX-31.1 18211
3 EX-31.2 itek-ex312_6.htm EX-31.2 18193
4 EX-32.1 itek-ex321_8.htm EX-32.1 13742
  Complete submission text file 0001564590-17-010064.txt   6224569

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itek-20170331.xml EX-101.INS 1453469
6 XBRL TAXONOMY EXTENSION SCHEMA itek-20170331.xsd EX-101.SCH 35144
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itek-20170331_cal.xml EX-101.CAL 33962
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itek-20170331_def.xml EX-101.DEF 147390
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itek-20170331_lab.xml EX-101.LAB 314475
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itek-20170331_pre.xml EX-101.PRE 240543
Mailing Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 17828483
SIC: 2834 Pharmaceutical Preparations